1. Home
  2. DRRX
  3. DRRX News

Latest DURECT Corporation (DRRX) News on August 6, 2025

DRRX

Associated Press Finance

3 months ago

Durect: Q1 Earnings Snapshot

DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
DRRX

PR Newswire

3 months ago

DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update

Here's Why We're A Bit Worried About DURECT's (NASDAQ:DRRX) Cash Burn Situation
DRRX

Simply Wall St.

4 months ago

Here's Why We're A Bit Worried About DURECT's (NASDAQ:DRRX) Cash Burn Situation

DRRX

Thomson Reuters StreetEvents

4 months ago

Q4 2024 DURECT Corp Earnings Call

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic Focus Amid Financial Challenges
DRRX

GuruFocus.com

4 months ago

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic Focus Amid Financial Challenges

Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates
DRRX

Zacks

4 months ago

Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates

DRRX

Associated Press Finance

4 months ago

Durect: Q4 Earnings Snapshot

DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
DRRX

PR Newswire

4 months ago

DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

What To Expect From Durect Corp (DRRX) Q4 2024 Earnings
DRRX

GuruFocus.com

4 months ago

What To Expect From Durect Corp (DRRX) Q4 2024 Earnings

ARS Pharmaceuticals, Inc. (SPRY) Q4 Earnings and Revenues Beat Estimates
DRRX

Zacks

5 months ago

ARS Pharmaceuticals, Inc. (SPRY) Q4 Earnings and Revenues Beat Estimates

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update
DRRX

PR Newswire

5 months ago

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
DRRX

PR Newswire

6 months ago

DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence
DRRX

PR Newswire

6 months ago

DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence

Durect (DRRX) Upgraded to Strong Buy: Here's Why
DRRX

Zacks

7 months ago

Durect (DRRX) Upgraded to Strong Buy: Here's Why

Durect (DRRX) Upgraded to Buy: Here's What You Should Know
DRRX

Zacks

8 months ago

Durect (DRRX) Upgraded to Buy: Here's What You Should Know

Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year?
DRRX

Zacks

8 months ago

Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year?

DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million
DRRX

PR Newswire

8 months ago

DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million

DRRX

Thomson Reuters StreetEvents

9 months ago

Q3 2024 DURECT Corp Earnings Call

Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ...
DRRX

GuruFocus.com

9 months ago

Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ...

Durect (DRRX) Reports Q3 Loss, Misses Revenue Estimates
DRRX

Zacks

9 months ago

Durect (DRRX) Reports Q3 Loss, Misses Revenue Estimates

DRRX

Associated Press Finance

9 months ago

Durect: Q3 Earnings Snapshot

DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
DRRX

PR Newswire

9 months ago

DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update

DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update
DRRX

PR Newswire

9 months ago

DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update

DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024
DRRX

PR Newswire

10 months ago

DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024

Durect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Advances Amid ...
DRRX

GuruFocus.com

10 months ago

Durect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Advances Amid ...

DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis
DRRX

PR Newswire

10 months ago

DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis

DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference
DRRX

PR Newswire

a year ago

DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference

DURECT Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
DRRX

Simply Wall St.

a year ago

DURECT Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Durect (DRRX) Reports Q2 Loss, Lags Revenue Estimates
DRRX

Zacks

a year ago

Durect (DRRX) Reports Q2 Loss, Lags Revenue Estimates

DRRX

Associated Press Finance

a year ago

Durect: Q2 Earnings Snapshot

DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update
DRRX

PR Newswire

a year ago

DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update

DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update
DRRX

PR Newswire

a year ago

DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update

Are Medical Stocks Lagging DURECT (DRRX) This Year?
DRRX

Zacks

a year ago

Are Medical Stocks Lagging DURECT (DRRX) This Year?

DRRX

MT Newswires

a year ago

Durect Gets FDA Breakthrough Therapy Designation for Alcohol-Related Hepatitis Treatment

DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
DRRX

PR Newswire

a year ago

DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis

DRRX

MT Newswires

a year ago

Durect Far From Earnings Story But FDA Commentary Shows Path Forward, Oppenheimer Says

DRRX

Thomson Reuters StreetEvents

a year ago

Q1 2024 DURECT Corp Earnings Call

DRRX

GuruFocus.com

a year ago

Durect Corp (DRRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Challenges ...

Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates
DRRX

Zacks

a year ago

Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates

DRRX

Associated Press Finance

a year ago

Durect: Q1 Earnings Snapshot

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
DRRX

PR Newswire

a year ago

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update

DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update
DRRX

PR Newswire

a year ago

DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update

DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis
DRRX

PR Newswire

a year ago

DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis

DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript
DRRX

Insider Monkey

a year ago

DURECT Corporation (NASDAQ:DRRX) Q4 2023 Earnings Call Transcript

Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates
DRRX

Zacks

a year ago

Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates

DRRX

Associated Press Finance

a year ago

Durect: Q4 Earnings Snapshot

DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
DRRX

PR Newswire

a year ago

DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update
DRRX

PR Newswire

a year ago

DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update

DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada
DRRX

PR Newswire

a year ago

DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada

Pacira (PCRX) Matches Q4 Earnings Estimates
DRRX

Zacks

a year ago

Pacira (PCRX) Matches Q4 Earnings Estimates

DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
DRRX

PR Newswire

a year ago

DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

DRRX

ACCESSWIRE

2 years ago

CSPi Technology Solutions Wins A Five-Year, Multi-Million Dollar, Managed Services Contract of a Prominent Florida Public College

One CSP Insider Raised Their Stake In The Previous Year
DRRX

Simply Wall St.

2 years ago

One CSP Insider Raised Their Stake In The Previous Year

O’keefe Stevens Started and Closed its Position in LL Flooring (LL)
DRRX

Insider Monkey

2 years ago

O’keefe Stevens Started and Closed its Position in LL Flooring (LL)

Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application
DRRX

GlobeNewswire

2 years ago

Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application

Mesa Air Group Enters New Agreements with United Airlines for Improved Operating and Financing Terms and Provides Update on CRJ-900 Asset Sale Program
DRRX

GlobeNewswire

2 years ago

Mesa Air Group Enters New Agreements with United Airlines for Improved Operating and Financing Terms and Provides Update on CRJ-900 Asset Sale Program

DRRX

GlobeNewswire

2 years ago

XBP Europe to Ring Nasdaq Opening Bell on January 5, 2024

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
DRRX

GlobeNewswire

2 years ago

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

Zevia to Participate in the 26th Annual ICR Conference
DRRX

Business Wire

2 years ago

Zevia to Participate in the 26th Annual ICR Conference

Ark Restaurants Corp. (NASDAQ:ARKR) Q4 2023 Earnings Call Transcript
DRRX

Insider Monkey

2 years ago

Ark Restaurants Corp. (NASDAQ:ARKR) Q4 2023 Earnings Call Transcript

Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?
DRRX

Zacks

2 years ago

Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?

Loop Media (LPTV) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
DRRX

Zacks

2 years ago

Loop Media (LPTV) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

10 Best Debt Free Penny Stocks To Buy Now
DRRX

Insider Monkey

2 years ago

10 Best Debt Free Penny Stocks To Buy Now

Individual investors account for 40% of Vox Royalty Corp.'s (TSE:VOXR) ownership, while institutions account for 36%
DRRX

Simply Wall St.

2 years ago

Individual investors account for 40% of Vox Royalty Corp.'s (TSE:VOXR) ownership, while institutions account for 36%

Zentek Announces Grant of Stock Options
DRRX

ACCESSWIRE

2 years ago

Zentek Announces Grant of Stock Options

What Makes Ashford Hospitality Trust (AHT) a New Buy Stock
DRRX

Zacks

2 years ago

What Makes Ashford Hospitality Trust (AHT) a New Buy Stock

CompoSecure Designated a Microsoft-Compatible FIDO2 Security Key Vendor for Passwordless Authentication
DRRX

GlobeNewswire

2 years ago

CompoSecure Designated a Microsoft-Compatible FIDO2 Security Key Vendor for Passwordless Authentication

Destra Multi Alternative Fund Announces the Approval of an Amended and Restated Declaration of Trust
DRRX

Business Wire

2 years ago

Destra Multi Alternative Fund Announces the Approval of an Amended and Restated Declaration of Trust

Yatra Online, Inc. Announces $5 Million Share Repurchase Authorization
DRRX

PR Newswire

2 years ago

Yatra Online, Inc. Announces $5 Million Share Repurchase Authorization

AGM Group Holdings Full Year 2022 Earnings: EPS: US$0.47 (vs US$0.17 in FY 2021)
DRRX

Simply Wall St.

2 years ago

AGM Group Holdings Full Year 2022 Earnings: EPS: US$0.47 (vs US$0.17 in FY 2021)

DRRX

Thomson Reuters StreetEvents

2 years ago

Q3 2023 DURECT Corp Earnings Call

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
DRRX

PR Newswire

2 years ago

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

DRRX

Associated Press Finance

2 years ago

Durect: Q3 Earnings Snapshot

DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update
DRRX

PR Newswire

2 years ago

DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update

Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for
DRRX

Zacks

2 years ago

Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for

NeoVolta Reports Q4 Sales Surge As Popular NV14 Home Solar Energy Storage Battery Shows Near Six-Figure Gross Revenues Over Last Six Weeks
DRRX

GlobeNewswire

2 years ago

NeoVolta Reports Q4 Sales Surge As Popular NV14 Home Solar Energy Storage Battery Shows Near Six-Figure Gross Revenues Over Last Six Weeks

DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update
DRRX

PR Newswire

2 years ago

DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update

KORU Medical Systems Inc (KRMD) Reports Q3 2023 Financial Results and Updates Full Year Outlook
DRRX

GuruFocus.com

2 years ago

KORU Medical Systems Inc (KRMD) Reports Q3 2023 Financial Results and Updates Full Year Outlook

DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on Mortality
DRRX

PR Newswire

2 years ago

DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on Mortality

InterCure Wins Cannolam Arbitration Proceeding
DRRX

GlobeNewswire

2 years ago

InterCure Wins Cannolam Arbitration Proceeding

Share on Social Networks: